Open access · OA
via OpenAlex
A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs
Silvan R. Urfer, Tammi L. Kaeberlein, Susan Mailheau, Philip J. Bergman, Kate E. Creevy, Daniel Promislow, Matt Kaeberlein
GeroScience · 2017 · ▲ 173 citations
Abstract
This randomized controlled trial from GeroScience 2017 examines the effects of short-term mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) treatment in a cohort of 24 middle-aged companion dogs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s11357-017-9972-z
- Canonical
- link ↗
- Fetched
- 2026-08-05 MST
Cite this
APA
Urfer, S.R., Kaeberlein, T.L., Mailheau, S., Bergman, P.J., Creevy, K.E., Promislow, D., & Kaeberlein, M. (2017). A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs. <em>GeroScience</em>. https://doi.org/10.1007/s11357-017-9972-z
Vancouver
Urfer SR, Kaeberlein TL, Mailheau S, Bergman PJ, Creevy KE, Promislow D, et al. A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs. GeroScience. 2017. doi:10.1007/s11357-017-9972-z.
BibTeX
@article{silvan2017Arando,
title = {A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs},
author = {Silvan R. Urfer and Tammi L. Kaeberlein and Susan Mailheau and Philip J. Bergman and Kate E. Creevy and Daniel Promislow and Matt Kaeberlein},
journal = {GeroScience},
year = {2017},
doi = {10.1007/s11357-017-9972-z},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Medicine 2024
Preprint · OA
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial
Gastroenterology 2014
Open access · OA
No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial
Federico II University 2022
Open access · US-GOV
Effects of a Nutraceutic Compound on Cognitive Impairment in Frailty Patients
University of Rochester 2024
Open access · US-GOV
A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer
Trends in Plant Science 2000
Preprint · OA
Molecular aspects of leaf senescence
Ruijin Hospital 2022
Open access · US-GOV